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Diabetes Mellitus affects 8.3% of the U.S. population and the prevalence, particularly of 
type 2 diabetes, is increasing alongside the growing overweight and obesity numbers (Centers for 
Disease Control and Prevention [CDC], 2011). Consequently, this chronic condition has become 
a serious public health concern, as many diagnoses of type 2 diabetes are considered preventable 
through physical activity, proper diet, weight loss, and tobacco cessation. The lack of 
comprehensive surveillance methods at the state level contributes to the ineffectiveness at 
reducing the incidence of diabetes, as the geographic trends reveal continued disparities.  
Surveillance is a fundamental tool in pushing forward the movement against diabetes. 
Better tracking, unification of methods, and accessible data sources could raise awareness and 
allow policy makers, patients, researchers, and the public to recognize the grave burden of 
diabetes. Acquiring and distributing this information is critical at the state level, since each state 
has varying prevalence numbers and environmental factors. Individuals cannot be expected to 
make positive lifestyle modifications and properly manage their conditions if they are not 
provided with the opportunities to do so, and these opportunities can only come with improved 
surveillance methods, research, and funding.  
This paper examines the burden of diabetes (type 2) through its life span: the rise in the 
prevalence among youths, adult diabetes, complications of diabetes (diabetic retinopathy, end-
stage renal disease, and lower limb amputations), and finally, death from diabetes. Findings from 
a literature and electronic search regarding current surveillance methods and data sources will be 
presented and the paper will conclude with recommendations for moving forward. Taking action 
to improve surveillance of diabetes and its complications would allow the cohesiveness 
necessary for states to effectively address this immense burden on society. 
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Introduction: Diabetes Mellitus (Focus on type 2) 
 Diabetes Mellitus is a chronic condition that affects 8.3% of the U.S. population (Centers 
for Disease Control and Prevention [CDC], 2011). The total estimated diabetes cost was $174 
billion in 2007 (CDC, 2011); this poses a severe burden on individuals with diabetes, insurers, 
and states with a high diabetes prevalence. Type 2 diabetes is the most common form of diabetes 
in which cells become resistant to insulin and ultimately the pancreas stops producing it (CDC, 
2011). This disease is a serious public health problem because it is a preventable non-
communicable disease and consequently, action needs to be taken at the state level. 
As prevalence of type 2 diabetes is growing in numbers, it is also expanding its reach to 
the younger population. Childhood diabetes is a growing concern as an increasing number of 
children form unhealthy dietary and physical activity patterns. As they grow into adults, they join 
the number of people who develop type 2 diabetes in adulthood. These individuals affected with 
diabetes then join the increasing number of individuals with immune-mediated and nonimmune-
mediated diabetes to develop complications of diabetes, such as diabetic retinopathy, end stage 
renal disease (ESRD), and lower limb amputations due to poorly controlled or severe diabetes. 
Finally, as a result of the complications and other comorbidities, death serves as the final marker 
in the life span of the disease. 
Purpose and Methods 
The value of state-level public health and social initiatives must be recognized in order to 
bring about changes. Healthy People 2020 suggests behavioral and social approaches for change, 
such as enhancing physical education classes for children, increasing the availability of healthy 
food and drinks in schools, and worksite lifestyle programs (U.S. Department of Health and 
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Human Services [DHHS], 2011). In addition, Healthy People 2020 lists objectives that affect 
policy at the state level, including “Increase the number of States that have State-level policies 
that incentivize food retail outlets to provide foods that are encouraged by the Dietary 
Guidelines” and “Increase the number of States with licensing regulations for physical activity 
provided in child care” (DHHS, 2011).  
States must make available these types of resources in order for their residents, especially 
those who are disadvantaged, to even have the option of making behavioral changes to avoid 
developing type 2 diabetes. Once changes are made at the state level, individual behavior change 
can follow, which would decrease the prevalence of overweight and obesity, and ultimately 
decrease the prevalence and incidence of diabetes.  
In order to raise awareness and support these crucial improvements, better surveillance 
methods must be executed at the state level. Surveillance is defined by the World Health 
Organization as the “systematic collection, analysis and interpretation of health data and the 
timely dissemination of this data to policymakers and others” (World Health Organization 
[WHO], 2011). Surveillance data is fundamental for raising awareness, setting policy measures, 
and planning for the future (WHO, 2011). The development of diabetes may be slowed or even 
prevented by providing the aforementioned resources to residents, but in order to do so, proper 
tracking, research, and translation of the research must be implemented. There is a need for state-
level information, which is more precise than direct estimates from surveys or administrative 
records (Srebotnjak, Mokdad, Murray, 2010).  
This paper reviews the burden and contributors of type 2 diabetes throughout the life 
span: childhood diabetes, diabetes in adults, complications, and deaths. It will also investigate 
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the availability of current state or national surveillance methods and data sources found through a 
literature and electronic database search. Finally, recommendations and strategies in moving 
forward will be discussed.  
 
Burden and Contributors 
Childhood Diabetes 
The growing prevalence of type 2 diabetes among children is alarming for many reasons: 
it is a reflection of increased weight gain at an early age and it presents difficulties and increased 
health risks for these individuals throughout their lives. The percentage of immune-mediated 
type 1 diabetes is slowly decreasing as the prevalence of nonimmune-mediated diabetes (mostly 
type 2) is increasing among children. Type 1 diabetes was thought to be the only type considered 
prevalent among children, but during 2002-2005, about 18.75% of children were newly 
diagnosed with type 2 diabetes (CDC, 2011). The SEARCH study, conducted by SEARCH for 
Diabetes in Youth, determined the prevalence of both types of diabetes among individuals < 20 
years to be 0.18% (Table 1; SEARCH for Diabetes in Youth Study Group, 2006). The group also 
estimated the number of newly diagnosed children and adolescents with type 2 diabetes in the 
U.S. to be approximately 3700 each year (The Writing Group for the SEARCH for Diabetes in 
Youth Study Group [SEARCH], 2007).  
While type 2 diabetes is still relatively uncommon among U.S. youth, a jump was 
observed in the diagnosis of type 2 from 0.4 per 100,000 per year to 8.5 per 100,000 per year 
between youth aged <10 years and youth aged 10-19 years (CDC, 2011). Adolescent minorities 
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aged 15-19 years show the highest rates, particularly American Indian youth at 49.4 per 100,000 
person-years (SEARCH, 2007). This highlights a significant public health problem, particularly 
as the proportion of minorities is increasing in the U.S. (Rosenbloom, Joe, Young & Winter, 
1999). Language barriers, low health literacy and education, and lack of health insurance are 
several factors among many that have a large bearing on minorities (Institute of Medicine [IOM], 
2002). These contributors, particularly low health literacy and education, may indirectly give rise 
to poor nutrition and other unhealthy behaviors, which in turn increase the likelihood of weight 
gain and consequently, the development of type 2 diabetes.  
Obesity serves as a marker for type 2 diabetes, with almost 85% of diabetic children 
either overweight or obese at the time of diagnosis (ADA, 2000). Obese children had over twice 
the odds of developing diabetes than those who were not overweight, with an odds ratio (OR) of 
2.67 for the 6 to 11 year-old age group and 2.45 in the 12 to 17 year-old age group (Lee, 
Herman, McPheeters & Gurney, 2006). Preventing and treating type 2 diabetes in the youth 
population can be challenging because of the behavioral and nonadherence trends.  
Children may find it difficult to reverse overweight and obesity, partly due to peer 
pressure to consume foods and beverages that are high in calories and sugar content. Many 
current social marketing strategies make unhealthy foods seem attractive, but this trend is 
reversing as more pressure and incentives are placed on improving nutrition and reducing obesity 
in children (Evans, Christoffel, Necheles & Becker, 2010). This particular age group, especially 
with the lack of symptoms, may also be more vulnerable to the denial of health status, resulting 
in dangerous nonadherence patterns for which children with diabetes are already at risk 
(Rosenbloom, Joe, Young & Winter, 1999). Adolescents in particular face new changes 
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physically, mentally, and emotionally during puberty, which makes managing and controlling 
diabetes even more challenging (CDC, 2001).  
 As diabetes worsens throughout childhood and into adulthood, youths may experience 
economic burden and a decreased quality of life. Particularly in children, poorly-controlled type 
2 diabetes affects present and future productivity in school and work and may result in an 
increased risk of morbidity and mortality throughout the most productive years of life. Pinhas-
Hamiel and Zeitler (2007) found that children and adolescents are prone to secondary obesity-
related complications such as metabolic syndrome and hypertension, which are associated with 
increased cardiovascular risk. This relationship signifies a need for the development of public 
health strategies to target overweight and obesity in youths to effectively reduce the future 
burden of diabetes in the U.S. (Lee, Herman, McPheeters & Gurney, 2006).  
 
Adult Diabetes 
From 1980 to 2009, the number of adults with diagnosed diabetes more than tripled to 
affect approximately 25.6 million men and women over the age of 20 (CDC, 2011). The 
pervasiveness of diabetes in the U.S. corresponds closely with obesity trends from state to state: 
Colorado, Connecticut, and Massachusetts have the lowest rates of obesity and also have lower 
rates of diabetes, while Alabama, Mississippi, and West Virginia have the highest rates of 
obesity and also of diabetes (Table 2; CDC, 2011). This trend highlights the alarming geographic 
patterns of obesity and diabetes, as the rising prevalence of diabetes either maintains or increases 
the disparities between regions of the U.S.  
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Colorado, which has the lowest prevalence of diabetes, has a population of which 20.7% 
are of Hispanic or Latino origin. In contrast, only 3.9% of residents in Alabama are of Hispanic 
or Latino origin and 26.2% black (U.S. Census Bureau, 2011). While Colorado’s percentage of 
individuals of Hispanic or Latino origin is significantly higher than Alabama’s, they have similar 
percentages of total minorities. The two states, however, are on opposites ends of the diabetes 
prevalence rankings, which emphasizes the fact that while minority status is a factor in diabetes 
risk, geography and environment play a large role in how likely individuals are to be diagnosed 
with diabetes. It may be valuable for states with these striking differences to compare health 
systems and discover exactly what states are doing to fight off obesity and diabetes. 
Minorities are at a higher risk of being affected by diabetes for several reasons, including 
low education and health literacy, lack of health insurance, language barriers, and cultural 
factors. In 2008, the age-adjusted prevalence of medically diagnosed diabetes among adults aged 
≥18 years was 11.0% black and 10.7% Hispanic, compared to 7.0% white, and the prevalence 
among black females was at 11.4% (Beckles, Zhu & Moonesinghe, 2011). In addition, the age-
adjusted diabetes-related ESRD incidence for Hispanics and blacks was 1.5 and 2.0 times higher 
than for whites in 2006 (Burrows, Li & Geiss, 2010). Among people who did not complete high 
school, 11.8% were diagnosed with diabetes (up from 9.7% in 2004) and among those who have 
greater than high school education level, only 6.2% have diabetes (Beckles, Zhu & 
Moonesinghe, 2011).  
The difference in education levels supports the idea that increased education has an 
inverse relationship with the likelihood of being diagnosed with diabetes. Those who have higher 
than a high school education are more likely to understand the risks of living an unhealthy 
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lifestyle, have increased health literacy and management of their health, and to be employed. In 
addition, the increases in prevalence and incidence rates from 2004 to 2008 of diagnosed 
diabetes between the groups with regards to education level reflect the increase in disparities 
between the education levels. 
Of individuals classified as poor (<1.0 poverty to income ratio), 11.7% have diabetes, 
while only 5.5% of high-income (≥4.0 poverty to income ratio) adults have diabetes (Beckles, 
Zhu & Moonesinghe, 2011). The CDC (2001) found that “reproductive-aged women with type 2 
diabetes have fewer years of education, lower incomes, and are less likely than women without 
diabetes to be employed.” Women are more affected by diabetes, with over half of the diabetic 
population being women (Beckles & Thompson-Reid, 2001). Since more women than men 
believe that interventions will be effective and that preventive behaviors will produce positive 
outcomes (Beckles & Thompson-Reid, 2001), this group may be an effective intervention 
approach. Women may be more open to changes and, depending on the family structure of a 
household, may be able to encourage successful lifestyle modifications within their families.  
Those with diabetes are twice as likely to suffer from depression as those without 
diabetes, which can pose considerable difficulties when attempting to manage diabetes (CDC, 
2011). These differences and challenges support the thought that the prevalence of diabetes is 
reflective of socio-economic status to an extent and is further stratified by the burden of the 
disease; individuals who suffer from diabetes must visit clinicians more often, may experience 
more sick days, and spend more money on illness. This creates an unhealthy cycle for some 
diabetic individuals with regards to employment, health status, mental and emotional conditions, 
and availability of health insurance and treatment options. 
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Both obesity and type 2 diabetes are largely preventable (Mokdad et al., 2003) but the 
required lifestyle modifications may seem overwhelming to individuals who are overweight or 
obese. Diet and physical activity habits are subject to time pressures and other priorities, such as 
taking care of children or working long hours. Overweight individuals increase their 
susceptibility to diabetes after additional weight gain (Resnick, Valsania, Halter, & Lin, 2000). 
However, overweight people who lose small amounts of weight decrease their risk of developing 
diabetes when compared to overweight individuals who maintain a stable weight: Resnick et al. 
(2000) found that losing approximately 22 pounds over 10 years was associated with a 33% 
reduction in diabetes in the next 10 years, relative to stable weight. In addition, Hu et al. (2001) 
estimated almost half of diabetes cases in overweight and normal weight women could have been 
prevented with lifestyle changes, such as abstinence from smoking, low alcohol consumption, 
healthy diet, and exercise (Hu et al., 2001). Obese women who practiced regular exercise and a 
healthy diet experienced a 24% reduction in risk of developing diabetes (Hu et al., 2001). 
Realistic weight loss goals in overweight individuals through dietary modifications and increased 
physical activity may substantially reduce the risk of diabetes.  
 
Complications of Diabetes 
 The burden of diabetes, particularly in the adult population, may be more accurately 
assessed by reviewing the top measureable complications of diabetes: diabetic retinopathy, end-
stage renal disease in the diabetic population, and lower limb amputations due to diabetes. These 
conditions all occur as a result of prolonged or poorly managed diabetes; therefore, using these 
as markers for severity is appropriate.  
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Diabetic Retinopathy 
Among adults aged 20-74 years, diabetic retinopathy is the leading cause of new cases of 
blindness (CDC, 2011). The risk for developing proliferative retinopathy is greater in females 
and by the age of 20, 40-60% of the U.S. population with diabetes will have retinopathy (CDC, 
2001). In one estimate, the crude prevalence rates were 40.3% for retinopathy and 8.2% for 
vision-threatening retinopathy among diabetic individuals (The Eye Diseases Prevalence 
Research Group, 2004). In the general U.S. population, the prevalence rates were 3.4% (4.1 
million people) for retinopathy (Table 3) and 0.75% (899,000 people) for vision-threatening 
retinopathy (The Eye Diseases Prevalence Research Group, 2004). 
Although diabetic retinopathy can only occur in individuals with diabetes, the prevalence 
of diabetes in the general U.S. population is great enough to make diabetic retinopathy 
considered highly prevalent (The Eye Diseases Prevalence Research Group, 2004). Given the 
aging U.S. population and increasing prevalence of diabetes, the prevalence of diabetic 
retinopathy will increase substantially by 2020 (The Eye Diseases Prevalence Research Group, 
2004). 
Health literacy concerns are also observed in diabetic retinopathy. Schillinger et al. 
(2002) found that 36% of patients with inadequate health literacy and 19% of patients with 
adequate health literacy reported to have retinopathy. Patients were more likely to report 
retinopathy if they were evaluated to have inadequate health literacy; this was checked against 
billing diagnoses of retinopathy and the results were reliable (Schillinger et al., 2002). Patients 
with inadequate health literacy had twice the odds of suffering from retinopathy, relative to 
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patients with adequate health literacy, even after adjusting for patient sociodemographics, 
diabetes education, treatment regimen, and duration of diabetes (Schillinger et al., 2002). 
 Understanding management and control of the disease is particularly important for 
diabetes, since it is preventable and can be treated to a degree. In one study, individuals with 
intensive glycemia treatment had a rate of diabetic retinopathy progression of 7.3%, while the 
standard therapy yielded a rate of 10.4% (The ACCORD Study Group and ACCORD Eye Study 
Group, 2010). Considering the high numbers of those affected by diabetic retinopathy, providing 
intensive care and management for diabetic patients would positively affect many individuals.   
End-Stage Renal Disease (ESRD) 
 Patients reach ESRD when they experience kidney failure, requiring dialysis or 
transplantation; this disease takes up more than 6% of the Medicare budget and has a high 
mortality rate (Burrows, Li & Geiss, 2010). The National Institutes of Health (NIH) spends $655 
million on kidney research and, including costs to other payers and expenses, the bill for treating 
ESRD is over $35 billion a year (The National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK), 2010). Those affected by diabetes make up the largest component of ESRD 
patients, with 44% of new cases of treated ESRD in 2006 being due to diabetes (Burrows, Li & 
Geiss, 2010). Although the health status of many diabetics is already poor, patients with chronic 
kidney disease are 16 to 40 times more likely to die instead of advancing to kidney failure 
(NIDDK, 2010). 
 Research has shown that diabetes-related ESRD incidence is declining (Burrows, Li & 
Geiss, 2010) and while it may indicate that current efforts are successful, the numbers are still 
extremely high. While the severity of diabetes may have decreased, the growing prevalence of 
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diabetes means that more are living with the condition. The surge of diabetes in the 1990’s also 
suggests that people have not had diabetes long enough to develop ESRD (Burrows, Li & Geiss, 
2010). In addition, the ADA modified the diagnostic criteria for diabetes, allowing less severe 
cases to qualify as diabetes and thereby increasing the value of the denominator in this equation, 
or the number of diabetic individuals (Burrows, Li & Geiss, 2010). 
Although ESRD is only one complication of many that diabetic patients may encounter, it 
is interesting to note the geographical differences in the state rankings of diabetes-related ESRD 
prevalence and diabetes prevalence (Table 4; CDC, 2011). The differences in the rankings could 
mean that the differences lie in the treatment of diabetes. For example, Tennessee is ranked at 
#47 for diabetes prevalence (rankings function from best to worst), but at #7 for diabetes-related 
ESRD. The relative gap in rankings could mean that while Tennessee has a high number of 
people developing diabetes, they are able to better manage the disease in order to avoid getting to 
the ESRD stage. On the other hand, Utah has a low prevalence of diabetes (ranked #3), but it is 
ranked #25 for ESRD. This difference, in contrast, could indicate that while Utah does not have 
many residents developing diabetes, it does not have enough systems and treatments in place to 
effectively handle the individuals who actually develop diabetes and progress to ESRD. 
Lower limb amputations  
Lower-extremity disease (LED) includes peripheral arterial disease (PAD) and peripheral 
neuropathy (PN). Most PAD patients are asymptomatic or the pain is shielded by the presence of 
peripheral neuropathy, resulting in low reporting rates, which makes it difficult to track (ADA, 
2003). When LED is not recognized and treated effectively, however, the complications may 
lead to nontraumatic amputations among diabetic patients (Gregg et al., 2004).  
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In the U.S., the age-adjusted amputation rate among diabetics is approximately 8/1,000 
patient-years with a prevalence of about 3% (ADA, 2003). Amputations among diabetics are 
indicative of poor glycemic and lipids control (Dorsey, Eberhardt, Gregg & Giess, 2009). 
Amputations can be considered preventable among diabetics, as early identification and better 
management would limit the number of severe infections in the lower extremities and 
consequent amputations (ADA, 2003). Smoking is considered to be the single most preventable 
risk factor; tobacco cessation and counseling is critical, as it would limit the complications of 
diabetes (ADA, 2003).  
Non-Hispanic whites are more likely to have adequate glycemic control and blood 
pressure control than blacks (Dorsey et al., 2009), reflecting similar patterns stated previously. 
This trend is to be expected, as a higher number of blacks would have diabetes and therefore be 
at risk for late-stage disease, leading to amputations. However, these continued disparities are 
disturbing, as it shows that type 2 diabetes and many of its complications are preventable to 
some extent and that this disease targets those with low health literacy, lower socioeconomic 
status, and consequently, those with decreased ability to manage their conditions.  
Early detection of diabetes and poor control of glucose and lipids, along with advocating 
smoking cessation, improved diet and physical activity, could decrease the number of diabetes-
related lower limb amputations (Dorsey et al., 2009). Late-stage disease, such as diabetic 
retinopathy, ESRD, and amputations, are blamed for the majority of health care morbidity, 
mortality, and costs among those with diabetes (Dorsey et al., 2009). Risk factor control and 
interventions focusing on disadvantaged populations may be key in bringing down lower limb 
amputations and as a result, decreasing the burden of diabetes (Dorsey et al., 2009).  
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Deaths from Diabetes 
 In 2007, diabetes was the seventh leading cause of death in the U.S. (CDC, 2011). The 
risk of death for people with diabetes is almost double that of their counterparts without diabetes 
(CDC, 2011). Particularly at older ages, adults face more complications including heart disease, 
stroke, and blindness, and their relative decline may be faster than for younger patients (CDC, 
2011). The Emerging Risk Factors Collaboration group (2011) noted strong positive associations 
of diabetes with deaths from renal and digestive diseases and infectious diseases, and diabetes 
was found to be associated with “substantial premature death” from various cancers, 
degenerative disorders, and external causes. The Emerging Risk Factors Collaboration group 
(2011) also observed that approximately 40% of the years of life lost from diabetes can be 
attributed to nonvascular conditions, including about 10% attributable to death from cancer. 
 
Surveillance and Potential Data Sources 
Childhood diabetes 
In order to support action, comprehensive population-based assessments and further 
research must be performed on childhood diabetes. Currently, the SEARCH / Diabetes in Youth 
Study is one of the only surveillance efforts designed specifically to identify “incident cases of 
DM among individuals younger than 20 years to estimate the population incidence of type 1, 
type 2, and other types of DM overall and by age and race/ethnicity” (SEARCH, 2007). This 
study surveys approximately 5.5 million children younger than 20 years of age at six SEARCH 
research centers in order to estimate incident cases of childhood diabetes each year (SEARCH, 
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2007). Although this estimate and others are useful for ongoing research and prevention efforts, 
undiagnosed diabetes and presymptomatic disease are not taken into account (Lee, Herman, 
McPheeters & Gurney, 2006), nor is geographic information available.  
Local areas and several countries have taken the initiative to set up childhood diabetes 
registries, such as the Chicago Childhood Diabetes Registry (Grigsby-Toussaint et al., 2010) and 
the Swedish Childhood Diabetes Registry (Hanberger, Samuelsson, Lindblad & Ludvigsson, 
2008). This method allows researchers to efficiently reach a target population and produce useful 
results. Grigsby-Toussaint et al. (2010) utilized the Chicago Childhood Diabetes Registry to 
study how socioeconomic characteristics in Chicago over a 30-year period may relate to 
neighborhood distribution of diabetes risk in children. The Swedish Childhood Diabetes Registry 
was used to examine the relationship between A1c and insulin regimen, duration of diabetes, 
age, sex, and BMI in adolescents (Hanberger, Samuelsson, Lindblad, & Ludvigsson, 2008). In 
this national registry, data is extracted from outpatient visits and registered locally in a special 
childhood diabetes program.  
As diabetes reaches more of the youth population, more attention must be given to 
tracking the prevalence and what may contribute to the rising numbers, particularly in various 
groups that are disproportionately affected. In addition, it may be worthwhile to examine the 
extent to which youth diagnosed with type 2 diabetes understand their disease process and 
methods of treatment to strengthen prevention and adherence endeavors (Rosenbloom, Joe, 
Young & Winter, 1999). Weight gain and childhood type 2 diabetes can be preventable, but this 
requires a dedicated community-based approach. The comprehensive assessment of childhood 
diabetes in the U.S., specifically at the state level, would push individuals and states to 
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acknowledge the epidemic and act as these children enter adulthood and further contribute to the 
burden of this disease.  
 
Adult diabetes 
 Currently, the Behavioral Risk Factor Surveillance System (BRFSS) is one of the only 
state-based monitoring systems for diabetes prevalence among adults. In this telephone survey, 
participants are asked, “has a doctor, nurse or other health professional ever told you that you 
have diabetes?” (CDC, 2011). Due to the fact that this database relies on random participants’ 
responses over the telephone, it is subject to self-reporting bias (of which recall bias is a concern) 
and is limited to households with telephones.  
As cellular phones are becoming more common, the validity of BRFSS is being 
questioned; in 2009, only about 63% of the U.S. used a landline as a source of phone 
communication (Mokdad, 2010). Landlines are also facing competition from telemarketers, 
which could discourage participation and may contribute to the significant decrease of survey 
response rates over the last 10-15 years (Mokdad, 2010). Despite these challenges, the overall 
national diabetes estimates between BRFSS and the National Health Interview Survey (NHIS), 
which includes both self-report and proxy data, were found to be similar, thereby strengthening 
the reliability of the two surveys (Nelson, Powell-Griner, Town, Kovar, 2003).  
Another surveillance system is The Dartmouth Atlas of Health Care, which is based off 
of Medicare claims and therefore only includes the Medicare beneficiary population. It uses 
small area analysis, a population-based methodology, to present prevalence information. Small 
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area analysis focuses on “the experience of the population living in a defined geographic area or 
the population that uses a specific hospital” (The Dartmouth Institute for Health Policy and 
Clinical Practice, 2011). The Dartmouth Institute, along with other researchers, uses the atlas for 
publications and reports, many focusing on the regional differences of various conditions and 
risk factors. It is useful in providing accurate numbers, such as in finding the percent of diabetic 
Medicare enrollees receiving a Hemoglobin A1c Test. However, it is limited in that it only 
provides information regarding Medicare enrollees- excluding those in managed care due to 
capitated payments- and with regards to diabetes, it only presents data on three screening 
procedures at the state level (The Dartmouth Institute for Health Policy and Clinical Practice, 
2011). 
Supplementing BRFSS and the Dartmouth Atlas are several data sources that have 
varying search criteria and presentation approaches. The Health Indicators Warehouse is a 
database organized by Agencies and Offices within the Department of Health and Human 
Services and is maintained by the National Center for Health Statistics. It is a compilation of 
national, state, and local health indicators and contains 28 indicators regarding diabetes, 
including “amputations among diabetics rate”, “trying to lose weight--persons with pre-
diabetes”, and “diabetes long-term complications admission rate” (National Center for Health 
Statistics, 2011). This particular database is useful because it provides relevant information at the 
state and local levels from a wide array of reliable sources such as Medicare claims, the U.S. 
Census population data, and secondary sources such as the U.S. Renal Data System, and the 
National Hospital Discharge Survey (NHDS). The Health Indicators Warehouse is cited by 
Healthy People 2020 for many measures concerning diabetes. 
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The Chronic Condition Data Warehouse presents information from Medicare and 
Medicaid claims and therefore only reflects those populations. It is a reliable source, as it is 
driven off of claims data, but only top-level information is accessible through the website. One 
must either create an account or “request data” in order to receive more detailed information.  
The MarketScan Commercial Claims and Encounters Database includes claims data from 
commercial, Medicare, and Medicaid populations but must be purchased for access. The 
Healthcare Cost and Utilization Project (HCUP) / State Inpatient Databases (SID), maintained by 
the Agency for Healthcare Research and Quality (AHRQ), is accurate and reliable due to the 
nature of its source, but only contains information from hospitals and 44 states at this time. 
Although there are many resources available, including ones not mentioned above, creating an 
easily accessible diabetes registry or other comprehensive methods of tracking would be 
convenient and provide the most accurate information for interested parties. 
 
Complications from diabetes 
 Diabetic retinopathy 
While estimates regarding diabetic retinopathy are readily available at the national level, 
it is unavailable at the local or state level (X. Zhang, CDC- Division of Diabetes Translation, 
personal communication, June 23, 2011). Considering the prevalence and impact of diabetic 
retinopathy, it would be useful to have this information available to affected individuals, 
organizations, and governments. This would provide direction in how and where to focus 
resources for diabetic retinopathy across the U.S.  
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Currently, collaborations such as the ACCORD Eye Study Group and The Eye Diseases 
Prevalence Research Group focus on diabetic retinopathy and preventing this complication. 
However, there is little emphasis on tracking diabetic retinopathy for the purpose of 
implementing policy change. Diabetic retinopathy could be monitored by creating a state-based 
registry for those diagnosed with diabetic retinopathy, by adding an additional question 
regarding this complication to current surveillance systems, or by using a “cutoff” Hemoglobin 
A1c level to serve as a marker for diabetic retinopathy (Cheng et al., 2009).  
ESRD 
Early detection, improved treatments, and better control of risk factors in diabetes must 
be in place for the numbers of ESRD patients and total diabetic patients to decline. The Chronic 
Kidney Disease Surveillance System is an on-going project run by the CDC/U.S. Department of 
Health and Human Services to monitor those with chronic kidney disease. In addition, the U.S. 
Renal Data System is useful in providing information on the number of patients who have 
ESRD. These programs are helpful in extracting numbers at the local and state levels in order to 
promote prevention; particularly due to the nature of ESRD, gathering the prevalence numbers 
by state is fairly straightforward (Table 4). 
Lower limb amputations 
 Diabetic individuals make up over 60% of people with non-traumatic lower-limb 
amputations (CDC, 2011). Information regarding amputations is available through the National 
Hospital Discharge Survey (NHDS), NHIS, and the Chronic Condition Data Warehouse / 
Centers for Medicare and Medicaid (Table 5). It is simple to track and the data is available at the 
state level from the Health Indicators Warehouse (pulled from the Chronic Condition Data 
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Warehouse), but it is often overlooked because the prevalence numbers are lower than those of 
the other complications. However, it is important to note the significance of having a lower 
extremity removed due to the inability to manage this disease. Healthy People 2020 lists it as an 
objective: “Reduce the rate of lower extremity amputations in persons with diagnosed diabetes” 
(DHHS, 2011).  
 
Deaths from diabetes 
Death from diabetes is recorded in death certificates and the data is reported by the 
National Center for Health Statistics. However, diabetes may be responsible for more deaths than 
reported, as it is often a co-morbidity and not necessarily the “event” that results in death. Many 
times, it is underreported: about 35% to 40% of people with diabetes who died had it listed 
anywhere on the death certificate and approximately 10% to 15% had diabetes listed as the 
underlying cause of death (CDC, 2011).  
 
Discussion 
Diabetes Registry 
A diabetes registry would be a worthwhile function in order to track development and 
complications of the disease to guide research in this field. Although a registry would only catch 
patients who have access to health care, this would be a more accurate measurement of the 
prevalence of diabetes than a self-reported survey or other current methods. It would reflect the 
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same proportions from state to state: individuals with diabetes over the total number of 
individuals who visited a clinician in a certain time period.  
Peterson et al. (2008) implemented an electronic diabetes registry to support their clinical 
intervention; a registry would be a useful tool not only for tracking the prevalence, but for 
supporting interventions and further research. The study, in which the registry played an integral 
role by providing functions such as reminders and monthly progress reviews, discovered 
statistically significant increases in diabetes process measures between control and intervention 
practices (Peterson et al., 2008).  
As reviewed earlier in the examples of the Chicago Childhood Diabetes Registry and the 
Swedish Childhood Diabetes Registry, it may be simpler to implement registries in more local or 
smaller areas. If this is the case, a registry system could be formed at the national level (in order 
to initiate consistency) but implemented at the county level. These counties could submit registry 
information to state health departments at a standardized interval, such as quarterly, which can 
then be rolled up for national estimates.  
The Institute of Medicine has developed a Committee on a National Surveillance System 
for Cardiovascular and Select Chronic Diseases. This action demonstrates that the IOM has 
recognized the need for a comprehensive surveillance system in order to effectively reduce the 
burden of diabetes and other chronic illnesses. The committee is hoping to build a framework for 
a national chronic disease surveillance system, which will include diabetes and will provide data 
for “analysis of race, ethnic, socioeconomic, and geographic region disparities in incidence and 
prevalence, functional health outcomes, measured risk factors, and clinical care delivery” 
(Institute of Medicine, 2011). The committee has held three meetings and the final report of the 
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committee is scheduled for release on July 22, 2011 (L. Hernandez, Institute of Medicine, 
personal communication, July 13, 2011). 
 
Moving Forward 
 The numbers that reveal the extreme burden of diabetes are staggering. However, a high 
number of undiagnosed individuals who have developed coping mechanisms to manage their 
health conditions may exist. Therefore, the burden of diabetes and people living with its 
complications may be even worse than presented in research, particularly since BRFSS and other 
commonly-used tracking methods do not include institutionalized individuals. It may be 
worthwhile to increase screening procedures to catch undiagnosed diabetic individuals; in order 
to make this a valuable practice; however, improved systems must be in place.  
 Opportunities for people to manage their health must be provided to identified patients; 
this is not the case for many. Since there are large socioeconomic, age, and ethic differences in 
the rates of diagnosed diabetes (Beckles, Zhu & Moonesinghe, 2011), many individuals with 
diabetes do not have the capacity to manage their illnesses. Resources must be provided to allow 
individuals to take control of their health situations, particularly with such a hindering disease as 
diabetes. It is imperative for action to be taken at the local level to implement more programs for 
health education and health literacy, and the growing environment for children must be enhanced 
so that future generations do not suffer from preventable diseases. As the prevalence of diabetes 
increases and takes a larger toll on the U.S., awareness of the cross cultural and socioeconomic 
disparities must be increased. 
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 As outlined throughout this paper, attention must be provided to all facets of the diabetes 
burden in order for interventions to be effective. A comprehensive view of development and 
opportunities to improve health and life chances across the spectrum of life must be emphasized 
(Wise, 2009). Children need resources as they grow, including safe outdoor environments that 
promote physical activity, proper nutrition, and access to health care. These positive efforts 
cannot be realized, however, without the emphasis on parents and adults and targeting not just 
from the bottom-up or top-down, but equally throughout the life span. The complications that 
arise and deaths that are attributable to diabetes must be properly surveyed in order for the 
resources to appear.   
Developing local programs coordinated by individuals who understand the environmental 
factors within communities must be priorities in order to target diabetes from developing and 
progressing. Promoting weight control, a balanced diet, and increased physical activity must be 
national priorities (Mokdad et al., 2003), as well as systems that guide individuals who are 
afflicted with diabetes to better manage their own health. These systems and programs can only 
come to fruition with funding and research, and these can be encouraged with accurate and 
comprehensive surveillance. 
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Table 1. Prevalence of Diabetes in Youth
Age group 
(years) Prevalence*
*Cases per 100,000 youth, 2001
0-9 79
10-19 280
Total 182
Source: SEARCH for Diabetes 
in Youth Study Group, 2006  
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Table 2. Prevalence of Adult Diabetes
State Prevalence* Rank
Alabama 13,200 51
Alaska 5,300 1
Arizona 11,400 48
Arkansas 9,600 33
California 8,600 24
Colorado 6,000 2
Connecticut 7,300 11
Delaware 8,700 25
District of Columbia 10,900 46
Florida 10,400 43
Georgia 9,700 34
Hawaii 8,300 20
Idaho 7,900 18
Illinois 8,700 26
Indiana 9,800 36
Iowa 7,500 14
Kansas 8,400 21
Kentucky 10,000 38
Louisiana 10,300 41
Maine 8,700 27
Maryland 9,300 31
Massachusetts 7,400 12
Michigan 10,100 39
Minnesota 6,700 4
Mississippi 12,400 50
Missouri 9,400 32
Montana 7,000 7
Nebraska 7,700 16
Nevada 8,500 22
New Hampshire 7,900 19
New Jersey 9,200 30
New Mexico 8,500 23
New York 8,900 29
North Carolina 9,800 37
North Dakota 7,400 13
Ohio 10,100 40
Oklahoma 10,400 44
Oregon 7,200 9
Pennsylvania 10,300 42
Rhode Island 7,800 17
South Carolina 10,700 45
South Dakota 6,900 6
Tennessee 11,300 47
Texas 9,700 35
Utah 6,500 3
Vermont 6,800 5
Virginia 8,700 28
Washington 7,600 15
West Virginia 11,700 49
Wisconsin 7,100 8
Wyoming 7,200 10 Source: BRFSS, 2010
*Affirmative responses 
per 100,000 adults, 2010
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Table 3. Prevalence of Diabetic Retinopathy
Age group 
(years)
Diabetic 
retinopathy*
40-49 1,380
50-64 3,780
65-74 5,810
≥ 75 4,960
Total 3,400
Source: The Eye Diseases 
Prevalence Research Group, 2004
*Prevalence per 100,000 persons, 
based on the 2000 US Census 
population
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Table 4. Prevalence of ESRD
State ESRD* Rank 
Alabama 212.2 38
Alaska 153.8 8
Arizona 225.5 42
Arkansas 186.6 21
California 234.4 46
Colorado 177.2 14
Connecticut 160.9 11
Delaware 210.6 36
District of Columbia 269.6 50
Florida 194.4 27
Georgia 180.7 18
Hawaii 450.0 51
Idaho 182.8 20
Illinois 177.3 16
Indiana 233.4 45
Iowa 166.6 12
Kansas 159.1 9
Kentucky 190.9 24
Louisiana 251.1 48
Maine 108.3 2
Maryland 207.6 35
Massachusetts 139.2 6
Michigan 197.8 29
Minnesota 167.0 13
Mississippi 199.5 30
Missouri 206.6 34
Montana 177.2 15
Nebraska 182.4 19
Nevada 187.2 22
New Hampshire 108.1 1
New Jersey 193.8 26
New Mexico 262.0 49
New York 202.2 32
North Carolina 223.2 41
North Dakota 216.9 39
Ohio 202.6 33
Oklahoma 201.7 31
Oregon 189.7 23
Pennsylvania 197.1 28
Rhode Island 138.3 5
South Carolina 230.3 43
South Dakota 249.6 47
Tennessee 146.4 7
Texas 210.9 37
Utah 192.8 25
Vermont 126.5 4
Virginia 217.0 40
Washington 160.7 10
West Virginia 177.4 17
Wisconsin 232.8 44
Wyoming 121.8 3
Source: CDC's Division of 
Diabetes Translation, 2011
*Total Rate of Adults Initiating 
Treatment for Diabetes-Related End-
Stage Renal Disease per 100,000 
Diabetic Population, 2007
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Table 5. Prevalence of Amputations
State Amputations* Rank
Alabama 110.64 39
Alaska -- --
Arizona 67.60 9
Arkansas 79.51 12
California 80.82 16
Colorado 54.93 2
Connecticut 119.13 41
Delaware 83.06 18
District of Columbia 100.81 31
Florida 70.10 10
Georgia 92.07 26
Hawaii 92.06 25
Idaho -- --
Illinois 83.71 19
Indiana 75.47 11
Iowa 51.74 1
Kansas 58.35 5
Kentucky 80.32 14
Louisiana 121.96 42
Maine 88.24 24
Maryland 103.58 34
Massachusetts 84.93 21
Michigan 84.95 22
Minnesota 55.87 4
Mississippi 134.91 43
Missouri 84.21 20
Montana -- --
Nebraska 80.23 13
Nevada 63.96 7
New Hampshire 80.76 15
New Jersey 102.88 33
New Mexico 87.70 23
New York 105.46 35
North Carolina 102.12 32
North Dakota -- --
Ohio 93.51 27
Oklahoma 94.00 28
Oregon 62.45 6
Pennsylvania 109.13 37
Rhode Island -- --
South Carolina 108.93 36
South Dakota -- --
Tennessee 109.27 38
Texas 114.82 40
Utah 55.52 3
Vermont -- --
Virginia 97.22 30
Washington 66.94 8
West Virginia 82.61 17
Wisconsin 94.41 29
Wyoming -- --
Source: Chronic Conditions 
Warehouse, 2008
*Amputations among diabetics 
rate (per 100,000 Medicare 
beneficiaries), aged 65-74 years, 
2008
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Table 6. Prevalence of Diabetic Deaths
State Deaths* Rank
Alabama 26.0 38
Alaska 23.4 27
Arizona 17.4 5
Arkansas 26.5 43
California 21.8 16
Colorado 16.7 4
Connecticut 15.8 2
Delaware 23.4 28
District of Columbia 25.2 36
Florida 21.1 15
Georgia 19.5 10
Hawaii 18.5 8
Idaho 22.7 22
Illinois 21.8 17
Indiana 23.4 29
Iowa 20.5 14
Kansas 22.8 23
Kentucky 24.1 32
Louisiana 33.3 50
Maine 21.9 19
Maryland 23.4 30
Massachusetts 16.6 3
Michigan 26.3 42
Minnesota 19.6 11
Mississippi 21.8 18
Missouri 22.3 21
Montana 23.1 24
Nebraska 23.3 26
Nevada 12.9 1
New Hampshire 20.1 13
New Jersey 24.4 33
New Mexico 32.7 49
New York 17.5 6
North Carolina 23.4 31
North Dakota 28.3 46
Ohio 29.1 47
Oklahoma 29.3 48
Oregon 27.0 44
Pennsylvania 22.0 20
Rhode Island 19.2 9
South Carolina 26.2 39
South Dakota 25.6 37
Tennessee 26.2 40
Texas 24.9 35
Utah 27.6 45
Vermont 24.4 34
Virginia 19.7 12
Washington 23.2 25
West Virginia 35.5 51
Wisconsin 18.3 7
Wyoming 26.2 41
Source: National Center for 
Health Statistics, 2010
*Diabetes Death Rate per 
100,000, age-adjusted, 2007
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